These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Törnell J J Clin Invest; 1997 Dec; 100(11):2744-51. PubMed ID: 9389738 [TBL] [Abstract][Full Text] [Related]
43. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672 [TBL] [Abstract][Full Text] [Related]
44. Effects of progesterone on normal and preneoplastic mammary development in mice in relation to prolactin and estrogen. Nagasawa H; Yanai R; Nakajima Y; Mori J Eur J Cancer (1965); 1980 Aug; 16(8):1069-77. PubMed ID: 6777165 [No Abstract] [Full Text] [Related]
45. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
46. Dysregulation of mammary Stats 1,3 and 5 and PRL receptors by overexpression of TGFalpha. Schroeder MD; Rose-Hellekant TA; Sandgren EP; Schuler LA Mol Cell Endocrinol; 2001 Apr; 175(1-2):173-83. PubMed ID: 11325527 [TBL] [Abstract][Full Text] [Related]
47. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Schroeder JA; Troyer KL; Lee DC Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574 [TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor-alpha mRNA and epidermal growth factor receptor mRNA expression in normal and neoplastic mammary glands of four strains of mice with different mammary tumor potentials. Tsunoda S; Ikezaki Y; Nagasawa H Zoolog Sci; 1997 Oct; 14(5):803-7. PubMed ID: 9450392 [TBL] [Abstract][Full Text] [Related]
49. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Witty JP; Lempka T; Coffey RJ; Matrisian LM Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342 [TBL] [Abstract][Full Text] [Related]
50. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Nørgaard P; Law B; Joseph H; Page DL; Shyr Y; Mays D; Pietenpol JA; Kohl NE; Oliff A; Coffey RJ; Poulsen HS; Moses HL Clin Cancer Res; 1999 Jan; 5(1):35-42. PubMed ID: 9918200 [TBL] [Abstract][Full Text] [Related]
51. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
52. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
53. Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice. Rose-Hellekant TA; Wentworth KM; Nikolai S; Kundel DW; Sandgren EP Am J Pathol; 2006 Nov; 169(5):1821-32. PubMed ID: 17071603 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant. Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785 [TBL] [Abstract][Full Text] [Related]
55. Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models. Blanco-Aparicio C; Cañamero M; Cecilia Y; Pequeño B; Renner O; Ferrer I; Carnero A PLoS One; 2010 Feb; 5(2):e9305. PubMed ID: 20174572 [TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs. Ben-Jonathan N; Chen S; Dunckley JA; LaPensee C; Kansra S Endocrinology; 2009 Feb; 150(2):795-802. PubMed ID: 18832099 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Moorehead RA; Fata JE; Johnson MB; Khokha R Cell Death Differ; 2001 Jan; 8(1):16-29. PubMed ID: 11313699 [TBL] [Abstract][Full Text] [Related]
58. Functional Significance of Selective Expression of ERα and ERβ in Mammary Gland Organ Culture. Mehta RG Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884959 [TBL] [Abstract][Full Text] [Related]
59. Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis. Segatto I; Zompit MM; Citron F; D'Andrea S; Vinciguerra GLR; Perin T; Berton S; Mungo G; Schiappacassi M; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B Cancer Res; 2019 Jan; 79(2):397-409. PubMed ID: 30478213 [TBL] [Abstract][Full Text] [Related]
60. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]